Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1994 Sep;32(9):2092–2098. doi: 10.1128/jcm.32.9.2092-2098.1994

Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection.

M Ruhnke 1, A Eigler 1, I Tennagen 1, B Geiseler 1, E Engelmann 1, M Trautmann 1
PMCID: PMC263948  PMID: 7814530

Abstract

After repeated use of fluconazole for therapy of oropharyngeal candidosis, the emergence of in vitro fluconazole-resistant Candida albicans isolates (MIC, > or = 25 micrograms/ml) together with oral candidosis unresponsive to oral dosages of up to 400 mg of fluconazole were observed in patients with human immunodeficiency virus (HIV) infection. Antifungal susceptibility testing was done by broth microdilution and agar dilution techniques on C. albicans isolates recovered from a cohort of patients with symptomatic HIV infection who were treated repeatedly with fluconazole for oropharyngeal candidosis. In vitro findings did show a gradual increase in the MICs for C. albicans isolates recovered from selected patients with repeated episodes of oropharyngeal candidosis. Primary resistance of C. albicans to fluconazole was not seen. Cross-resistance in vitro occurred between fluconazole and other azoles (ketoconazole, itraconazole), but to a lesser extent. The results of the study suggest that the development of clinical resistance to fluconazole could be clearly correlated to in vitro resistance to fluconazole. Itraconazole may still serve as an effective antifungal agent in patients with HIV infection and oropharyngeal candidosis nonresponsive to fluconazole.

Full text

PDF
2092

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bart-Delabesse E., Boiron P., Carlotti A., Dupont B. Candida albicans genotyping in studies with patients with AIDS developing resistance to fluconazole. J Clin Microbiol. 1993 Nov;31(11):2933–2937. doi: 10.1128/jcm.31.11.2933-2937.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cameron M. L., Schell W. A., Bruch S., Bartlett J. A., Waskin H. A., Perfect J. R. Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1. Antimicrob Agents Chemother. 1993 Nov;37(11):2449–2453. doi: 10.1128/aac.37.11.2449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. De Wit S., Weerts D., Goossens H., Clumeck N. Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS. Lancet. 1989 Apr 8;1(8641):746–748. doi: 10.1016/s0140-6736(89)92572-5. [DOI] [PubMed] [Google Scholar]
  4. Defever K. S., Whelan W. L., Rogers A. L., Beneke E. S., Veselenak J. M., Soll D. R. Candida albicans resistance to 5-fluorocytosine: frequency of partially resistant strains among clinical isolates. Antimicrob Agents Chemother. 1982 Nov;22(5):810–815. doi: 10.1128/aac.22.5.810. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dupont B., Drouhet E. Fluconazole in the management of oropharyngeal candidosis in a predominantly HIV antibody-positive group of patients. J Med Vet Mycol. 1988 Feb;26(1):67–71. doi: 10.1080/02681218880000081. [DOI] [PubMed] [Google Scholar]
  6. Espinel-Ingroff A., Kerkering T. M., Goldson P. R., Shadomy S. Comparison study of broth macrodilution and microdilution antifungal susceptibility tests. J Clin Microbiol. 1991 Jun;29(6):1089–1094. doi: 10.1128/jcm.29.6.1089-1094.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Esposito R., Castagna A., Uberti Foppa C. Maintenance therapy of oropharyngeal candidiasis in HIV-infected patients with fluconazole. AIDS. 1990 Oct;4(10):1033–1034. [PubMed] [Google Scholar]
  8. Fan-Havard P., Capano D., Smith S. M., Mangia A., Eng R. H. Development of resistance in candida isolates from patients receiving prolonged antifungal therapy. Antimicrob Agents Chemother. 1991 Nov;35(11):2302–2305. doi: 10.1128/aac.35.11.2302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Feigal D. W., Katz M. H., Greenspan D., Westenhouse J., Winkelstein W., Jr, Lang W., Samuel M., Buchbinder S. P., Hessol N. A., Lifson A. R. The prevalence of oral lesions in HIV-infected homosexual and bisexual men: three San Francisco epidemiological cohorts. AIDS. 1991 May;5(5):519–525. doi: 10.1097/00002030-199105000-00007. [DOI] [PubMed] [Google Scholar]
  10. Gordon M. A., Lapa E. W., Passero P. G. Improved method for azole antifungal susceptibility testing. J Clin Microbiol. 1988 Sep;26(9):1874–1877. doi: 10.1128/jcm.26.9.1874-1877.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hughes C. E., Beggs W. H. Action of fluconazole (UK-49,858) in relation to other systemic antifungal azoles. J Antimicrob Chemother. 1987 Feb;19(2):171–174. doi: 10.1093/jac/19.2.171. [DOI] [PubMed] [Google Scholar]
  12. Just-Nübling G., Gentschew G., Döhle M., Böttinger C., Helm E. B., Stille W. Fluconazole in the treatment of oropharyngeal candidosis in HIV-positive patients. Mycoses. 1990 Sep-Oct;33(9-10):435–440. doi: 10.1111/myc.1990.33.9-10.435. [DOI] [PubMed] [Google Scholar]
  13. Kerridge D., Nicholas R. O. Drug resistance in the opportunistic pathogens Candida albicans and Candida glabrata. J Antimicrob Chemother. 1986 Oct;18 (Suppl B):39–49. doi: 10.1093/jac/18.supplement_b.39. [DOI] [PubMed] [Google Scholar]
  14. Kitchen V. S., Savage M., Harris J. R. Candida albicans resistance in AIDS. J Infect. 1991 Mar;22(2):204–205. doi: 10.1016/0163-4453(91)91789-z. [DOI] [PubMed] [Google Scholar]
  15. Koletar S. L., Russell J. A., Fass R. J., Plouffe J. F. Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with human immunodeficiency virus. Antimicrob Agents Chemother. 1990 Nov;34(11):2267–2268. doi: 10.1128/aac.34.11.2267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Korting H. C., Ollert M., Georgii A., Fröschl M. In vitro susceptibilities and biotypes of Candida albicans isolates from the oral cavities of patients infected with human immunodeficiency virus. J Clin Microbiol. 1988 Dec;26(12):2626–2631. doi: 10.1128/jcm.26.12.2626-2631.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Leen C. L., Dunbar E. M., Ellis M. E., Mandal B. K. Once-weekly fluconazole to prevent recurrence of oropharyngeal candidiasis in patients with AIDS and AIDS-related complex: a double-blind placebo-controlled study. J Infect. 1990 Jul;21(1):55–60. doi: 10.1016/0163-4453(90)90646-p. [DOI] [PubMed] [Google Scholar]
  18. Miyasaki S. H., Hicks J. B., Greenspan D., Polacheck I., MacPhail L. A., White T. C., Agabian N., Greenspan J. S. The identification and tracking of Candida albicans isolates from oral lesions in HIV-seropositive individuals. J Acquir Immune Defic Syndr. 1992 Oct;5(10):1039–1046. [PubMed] [Google Scholar]
  19. Ng T. T., Denning D. W. Fluconazole resistance in Candida in patients with AIDS--a therapeutic approach. J Infect. 1993 Mar;26(2):117–125. doi: 10.1016/0163-4453(93)92707-4. [DOI] [PubMed] [Google Scholar]
  20. Nightingale S. D., Cal S. X., Peterson D. M., Loss S. D., Gamble B. A., Watson D. A., Manzone C. P., Baker J. E., Jockusch J. D. Primary prophylaxis with fluconazole against systemic fungal infections in HIV-positive patients. AIDS. 1992 Feb;6(2):191–194. doi: 10.1097/00002030-199202000-00008. [DOI] [PubMed] [Google Scholar]
  21. Pfaller M. A., Dupont B., Kobayashi G. S., Müller J., Rinaldi M. G., Espinel-Ingroff A., Shadomy S., Troke P. F., Walsh T. J., Warnock D. W. Standardized susceptibility testing of fluconazole: an international collaborative study. Antimicrob Agents Chemother. 1992 Sep;36(9):1805–1809. doi: 10.1128/aac.36.9.1805. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Pfaller M. A., Rhine-Chalberg J., Redding S. W., Smith J., Farinacci G., Fothergill A. W., Rinaldi M. G. Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. J Clin Microbiol. 1994 Jan;32(1):59–64. doi: 10.1128/jcm.32.1.59-64.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Pfaller M. A., Rinaldi M. G., Galgiani J. N., Bartlett M. S., Body B. A., Espinel-Ingroff A., Fromtling R. A., Hall G. S., Hughes C. E., Odds F. C. Collaborative investigation of variables in susceptibility testing of yeasts. Antimicrob Agents Chemother. 1990 Sep;34(9):1648–1654. doi: 10.1128/aac.34.9.1648. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Ryley J. F., Wilson R. G., Barrett-Bee K. J. Azole resistance in Candida albicans. Sabouraudia. 1984;22(1):53–63. [PubMed] [Google Scholar]
  25. Sandven P., Bjørneklett A., Maeland A. Susceptibilities of Norwegian Candida albicans strains to fluconazole: emergence of resistance. The Norwegian Yeast Study Group. Antimicrob Agents Chemother. 1993 Nov;37(11):2443–2448. doi: 10.1128/aac.37.11.2443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Sanguineti A., Carmichael J. K., Campbell K. Fluconazole-resistant Candida albicans after long-term suppressive therapy. Arch Intern Med. 1993 May 10;153(9):1122–1124. [PubMed] [Google Scholar]
  27. Schmid J., Odds F. C., Wiselka M. J., Nicholson K. G., Soll D. R. Genetic similarity and maintenance of Candida albicans strains from a group of AIDS patients, demonstrated by DNA fingerprinting. J Clin Microbiol. 1992 Apr;30(4):935–941. doi: 10.1128/jcm.30.4.935-941.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Sekhon A. S., Garg A. K., Hamir Z. Effect of culture media on in vitro susceptibility testing of fluconazole against some yeasts. Mycoses. 1991 Jul-Aug;34(7-8):319–322. doi: 10.1111/j.1439-0507.1991.tb00668.x. [DOI] [PubMed] [Google Scholar]
  29. Shawar R., Paetznick V., Witte Z., Ensign L. G., Anaissie E., LaRocco M. Collaborative investigation of broth microdilution and semisolid agar dilution for in vitro susceptibility testing of Candida albicans. J Clin Microbiol. 1992 Aug;30(8):1976–1981. doi: 10.1128/jcm.30.8.1976-1981.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Smith D., Boag F., Midgley J., Gazzard B. Fluconazole resistant candida in AIDS. J Infect. 1991 Nov;23(3):345–346. doi: 10.1016/0163-4453(91)93584-y. [DOI] [PubMed] [Google Scholar]
  31. Smith K. J., Warnock D. W., Kennedy C. T., Johnson E. M., Hopwood V., Van Cutsem J., Vanden Bossche H. Azole resistance in Candida albicans. J Med Vet Mycol. 1986 Apr;24(2):133–144. [PubMed] [Google Scholar]
  32. Stevens D. A., Greene S. I., Lang O. S. Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome-related complex. Randomized, double-blind, placebo-controlled study of 100-mg oral fluconazole daily. Arch Intern Med. 1991 Dec;151(12):2458–2464. [PubMed] [Google Scholar]
  33. Torssander J., Morfeldt-Månson L., Biberfeld G., Karlsson A., Putkonen P. O., Wasserman J. Oral candida albicans in HIV infection. Scand J Infect Dis. 1987;19(3):291–295. doi: 10.3109/00365548709018473. [DOI] [PubMed] [Google Scholar]
  34. Tschechne B., Brunkhorst U., Ruhnke M., Trautmann M., Dempe S., Deicher H. Fluconazol in der Therapie der Kandidose des Mund-Rachen-Raumes bei Patienten mit HIV-Infektion. Ergebnisse einer offenen multizentrischen Studie zum Nachweis der Wirksamkeit und Verträglichkeit von Fluconazol. Med Klin (Munich) 1991 Oct 15;86(10):508–511. [PubMed] [Google Scholar]
  35. Warnock D. W., Burke J., Cope N. J., Johnson E. M., von Fraunhofer N. A., Williams E. W. Fluconazole resistance in Candida glabrata. Lancet. 1988 Dec 3;2(8623):1310–1310. doi: 10.1016/s0140-6736(88)92919-4. [DOI] [PubMed] [Google Scholar]
  36. Weber S., Polak-Wyss A. Das Resistenzverhalten von Sprosspilzisolaten aus definierten Probandengruppen gegenüber 5-Fluorcytosin. Mycoses. 1991;34 (Suppl 1):77–81. [PubMed] [Google Scholar]
  37. Willocks L., Leen C. L., Brettle R. P., Urquhart D., Russell T. B., Milne L. J. Fluconazole resistance in AIDS patients. J Antimicrob Chemother. 1991 Dec;28(6):937–939. doi: 10.1093/jac/28.6.937. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES